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We read with interest a recent article by Papanicolaou and colleagues (1) about the burden of 
vancomycin-resistant Enterococcus (VRE) bloodstream infection (BSI) in patients after allogeneic 
hematopoietic cell transplantation. VRE BSI was associated with lower overall survival and higher 
nonrelapse mortality compared to patients with non-VRE BSI or without BSI altogether.  
In this cohort study, BSI was defined as a bacterial organism reported from the blood/buffy coat 
obtained either from peripheral blood or a central venous catheter; clinical information about the 
relevance of these detections was not available. The Figure S1 (Supplementary data) illustrates that 
27% of all BSI (corresponding to approximately 30% of the non-VRE BSI) were due to coagulase-
negative staphylococci (CoNS, i.e., typical skin contaminants in blood cultures that frequently have no 
clinical relevance) (2, 3).  However, in every comparative study the most appropriate comparator 
needs to be carefully selected because it influence the results. Given the pathogen mix in the 
comparator group chosen here, we believe sensitivity analyses are lacking. For example, it would be 
very interesting to repeat the Cox model excluding typical skin contaminants. Moreover, it would be 
useful to compare the impact of VRE to that of Staphylococcus aureus and of nonfermenting Gram-
negative bacilli, respectively. 
In addition, in a large cohort study, Kramer et al. (4) observed that E. faecium in blood cultures was 
an independent risk factor for in-hospital mortality and prolonged the hospital stay. In other words, 
vancomycin resistance did not further increase the mortality or morbidity among patients with E. 
faecium isolates. A specific sub-group analysis comparing vancomycin-resistant E. faecium with 
vancomycin-sensitive E. faecium would therefore also be of interest.  
While the authors are to be commended for their work, we believe these additional analyses would 
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